- Home
- CELC vs HAYW Comparison
CELC vs HAYW Comparison
Compare CELC & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | HAYW |
|---|---|---|
| Founded | 2011 | 1925 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CELC | HAYW |
|---|---|---|
| Price | $120.90 | $15.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $112.56 | $17.50 |
| AVG Volume (30 Days) | 649.3K | ★ 1.9M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $1,122,155,000.00 |
| Revenue This Year | N/A | $6.22 |
| Revenue Next Year | $720.19 | $5.96 |
| P/E Ratio | ★ N/A | $23.19 |
| Revenue Growth | N/A | ★ 6.71 |
| 52 Week Low | $9.64 | $12.94 |
| 52 Week High | $129.09 | $17.73 |
Technical Indicators
Market Signals| Indicator | CELC | HAYW |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 65.56 |
| Support Level | $99.38 | $15.50 |
| Resistance Level | N/A | $16.66 |
| Average True Range (ATR) | 7.46 | 0.40 |
| MACD | -0.18 | 0.16 |
| Stochastic Oscillator | 63.82 | 85.80 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.